Remove 2014 Remove Genetics and mental health Remove Pharmaceuticals
article thumbnail

Critical Psychiatry Textbook, Chapter 16: Is There Any Future for Psychiatry? (Part Six)

Mad in America

Schatzberg has served as a consultant to or received honoraria from Abbott, Bristol-Myers Squibb, Corcept Therapeutics, Forest Laboratories, Janssen, Eli Lilly, Merck, Mitsubishi Pharmaceuticals, Organon, ParkeDavis, Pfizer, Pharmacia–Upjohn, Sanofi, Scirex, SmithKline Beecham, Solvay, and Wyeth–Ayerst. 695 This is sickening.

article thumbnail

On Not Becoming David Foster Wallace

Mad in America

I didn’t know Wallace was a poster boy for antidepressant withdrawal because I didn’t know that antidepressant withdrawal was common, or that I would be experiencing it myself and understanding firsthand the hellish bodily and mental feelings that make one long for death, for everything to stop. There are no studies, not yet.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Undisclosed Financial Conflicts of Interest in the DSM-5: An Interview with Lisa Cosgrove and Brian Piper

Mad in America

Mad in America has previously examined the problems with conflicts of interest in research but this time we extend that to look at the potential effect of COIs on diagnostic tools such as the Diagnostic and Statistical Manual of Mental Disorders (DSM). He wanted his friends to use this drug, he wanted his family members to use this drug.

article thumbnail

Part 4: Neurodiversity: New Paradigm, or Trojan Horse?

Mad in America

Within this, some parts of the neurodiversity movement take an uncritical or neutral perspective on the validity of psychiatric diagnoses such as—but not limited to—ASD and ADHD, backed up by unsubstantiated claims about biological and genetic causal factors. This heterogeneity makes it difficult to generalise.

article thumbnail

Why Failed Psychiatry Lives On: Its Industrial Complex, Politics, & Technology Worship

Mad in America

Thomas Insel, director of the National Institute of Mental Health (NIMH) from 2002-2015, acknowledged in 2011, “Whatever we’ve been doing for five de­cades, it ain’t working. adults now takes an antidepressant”; however, Time continued, “Mental health is getting worse by multiple metrics. As of late 2022, just 31% of U.S.